Hazim Ansari is a pioneer in the offshore intellectual property industry and a successful entrepreneur. A co-founder and CEO of Novel IP, Hazim has advised numerous established and emerging companies on their patent portfolios, including Xerox, Fresenius Medical Care, Activision, Spacelabs Healthcare, Rapiscan Systems, EndoChoice, Glucon, Hythiam, Xcorporeal, Crowdgather, Quartics, EndoStim, Lipid Sciences, HDL Therapeutics, Applied Utility Systems, and Elira, among others. He has negotiated licensing deals with over 50 universities and various U.S. government agencies, including the first ever privately held corporate consortium to conduct medical research using antimatter. He co-founded Network Signatures, which was one of the largest patent royalty-generating revenue companies for the U.S. Navy. He also co-founded several biomedical device companies, including SynerZ Medical (acquired in 2016), Aqua Medical, Aqua Cardio, Hridaya, and Spiranetics. In 2002, Hazim founded PatentMetrix, now named Novel IP, based in Delhi, India and was one of the first to use this high quality, cost-effective labor base to deliver patent services, such as patent drafting, mapping markets to help companies proactively manage patent infringement risk and building multi-institutional collaborations to further technology development.
Prior to founding PatentMetrix, Mr. Ansari was an executive at the Tomorrow Factory, a B2B software company and an intellectual property attorney in O’Melveny & Myers’ Newport Beach office where he represented numerous high technology companies in the negotiation of intellectual property licensing and acquisition deals, filing and prosecution of patent portfolios, structuring of co-development and co-exploitation vehicles, and general management of intellectual property assets. Mr. Ansari began his intellectual property career as an associate at Christie, Parker & Hale. He graduated magna cum laude from Loyola Law School of Los Angeles and received his B.S. in Chemical Engineering from Stanford University.